Literature DB >> 28149855

Genomic predictor of complete response after chemoradiotherapy in rectal cancer.

Gyoung Tae Noh1, Nam Kyu Kim1.   

Abstract

Entities:  

Year:  2016        PMID： 28149855      PMCID： PMC5233494          DOI： 10.21037/atm.2016.12.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

Review 3.  Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Authors:  Chiara Molinari; Federica Matteucci; Paola Caroli; Alessandro Passardi
Journal:  Clin Colorectal Cancer       Date:  2015-06-06       Impact factor: 4.481

Review 4.  Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment.

Authors:  B Glimelius; U Isacsson; B Jung; L Påhlman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-15       Impact factor: 7.038

5.  Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.

Authors:  Emmanouil Fokas; Torsten Liersch; Rainer Fietkau; Werner Hohenberger; Tim Beissbarth; Clemens Hess; Heinz Becker; Michael Ghadimi; Karl Mrak; Susanne Merkel; Hans-Rudolf Raab; Rolf Sauer; Christian Wittekind; Claus Rödel
Journal:  J Clin Oncol       Date:  2014-04-21       Impact factor: 44.544

6.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

Review 7.  Rectum-conserving surgery in the era of chemoradiotherapy.

Authors:  F M Smith; D Waldron; D C Winter
Journal:  Br J Surg       Date:  2010-12       Impact factor: 6.939

8.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

9.  The epidermal growth factor receptor mediates radioresistance.

Authors:  Ke Liang; K Kian Ang; Luka Milas; Nancy Hunter; Zhen Fan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038

Review 10.  New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer.

Authors:  Nam Kyu Kim; Hyuk Hur
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759
View more
  1 in total

1.  Prediction of Response to Neoadjuvant Chemoradiotherapy by MRI-Based Machine Learning Texture Analysis in Rectal Cancer Patients.

Authors:  Sajad P Shayesteh; Afsaneh Alikhassi; Farshid Farhan; Reza Ghalehtaki; Masume Soltanabadi; Peiman Haddad; Ahmad Bitarafan-Rajabi
Journal:  J Gastrointest Cancer       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.